Fieke M. Cox

Fieke M. Cox

Auto-generated profile, based on publicly available information

Fieke M. Cox

Department of Neurology, Leiden University Medical Centre, 2300 RC Leiden, The Netherlands

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 September 2011 in Brain
Verified
Journal Article
Open access
PDF file
FCFieke M. Cox
Fieke M. Cox
MTMaarten J. Titulaer
Maarten J. Titulaer
JSJacob Sont
Jacob Sont
AWAxel R. Wintzen
Axel R. Wintzen
JVJan J. G. M. Verschuuren
Jan J. G. M. Verschuuren
UBUmesh A. Badrising
Umesh A. Badrising
Sporadic inclusion body myositis is considered to be a slowly progressive myopathy. Long-term follow-up data are, however, not yet available. Follow-up data are important with a view to informing patients about their prognosis and selecting appropriate outcome measures for clinical trials. We performed a follow-up study of 64 patients with sporadic inclusion body myositis who participated in a national epidemiological study in the Netherlands. Case histories were recorded, and manual and quantitative muscle tests as well as laboratory tests were performed at baseline and 12 years (median) after the first out-patient visit. Date and cause of death were recorded for all deceased patients. Forty-six patients died during the follow-up period, two patients chose not to participate and one patient was lost to follow-up. The remaining 15 surviving patients had a mean disease duration of 20 years and were clinically evaluated at the second time point. The mean decline in strength was 3.5 and 5.4% per year according to the manual muscle testing and quantitative muscle testing, respectively. This decline was most pronounced in the lower legs, which were also the weakest extremities. Life expectancy was normal at 81 years, but activities of daily life were clearly restricted. At follow-up, all patients were found to be using a wheelchair, seven of them (47%) being completely wheelchair-bound. Disorders of the respiratory system were the most common cause of death. In three patients, euthanasia was requested and in another three, continuous deep sedation was applied. The fact that end-of-life care interventions were used in six patients (13%) reflects the severe disability and loss of quality of life at the end stage of this disease. Sporadic inclusion body myositis is a chronic progressive disorder, leading to major disabilities at the end stage of the disease due to extensive muscle weakness.

2 February 2011 in Rheumatology
Verified
Journal Article
Open access
PDF file
FCFieke M. Cox
Fieke M. Cox
MRMonique Reijnierse
Monique Reijnierse
CRCarla S. P. van Rijswijk
Carla S. P. van Rijswijk
AWAxel R. Wintzen
Axel R. Wintzen
JVJan J. Verschuuren
Jan J. Verschuuren
UBUmesh A. Badrising
Umesh A. Badrising
Objective. To analyse whether MRI of upper and lower extremity muscles in a large patient group with sporadic IBM (sIBM) is of additional value in the diagnostic work-up of sIBM. Methods. Thirty-two sIBM patients were included. Magnetic resonance (MR) parameters evaluated in 68 muscles of upper and lower extremity were muscle atrophy, fatty infiltration and inflammation. These findings were correlated with disease duration, weakness and serum creatine kinase (sCK) levels. Results. Fatty infiltration was far more common than inflammation. Muscles most frequently infiltrated with fat were the flexor digitorum profundus (FDP), anterior muscles of the upper leg and all muscles of the lower leg, preferentially the medial part of the gastrocnemius. The rectus femoris was relatively spared compared with other quadriceps muscles as well as the adductors of the upper leg. Inflammation was common in general, but individually sparse, present in 78% of the patients with a median of two inflamed muscles per patient. A statistically significant correlation was found between the amount of fatty infiltration and disease severity, disease duration and sCK. Conclusion. We provide a detailed description of the MRI in sIBM and show a distinct pattern of muscle involvement. Relatively severe affliction of the medial compartment of the gastrocnemius, combined with relative sparing of the rectus femoris or involvement of the FDP can be indicative of sIBM. MRI can contribute to the diagnosis in selected patients with clear clinical suspicion, but lacking the mandatory set of muscle biopsy features.

15 July 2009 in Journal of Neurology
Verified
Journal Article
Open access
PDF file
FCF. M. Cox
F. M. Cox
JVJ. J. Verschuuren
J. J. Verschuuren
BVBerit Verbist
Berit Verbist
ENE. H. Niks
E. H. Niks
AWA. R. Wintzen
A. R. Wintzen
UBU. A. Badrising
U. A. Badrising
Dysphagia is an important yet inconsistently recognized symptom of inclusion body myositis (IBM). It can be disabling and potentially life-threatening. We studied the prevalence and symptom-sign correlation of dysphagia. Fifty-seven IBM patients were interviewed using a standard questionnaire for dysphagia and 43 of these underwent swallowing videofluoroscopy (VFS). Symptoms of dysphagia were present in 37 of 57 patients (65%). Nevertheless, only 17 of these patients (46%) had previously and spontaneously complained about swallowing to their physicians. Both symptoms of impaired propulsion (IP) (59%) and aspiration-related symptoms (52%) were frequently mentioned. Swallowing abnormalities on VFS were present in 34 of 43 patients (79%) with IP of the bolus in 77% of this group. The reported feeling of IP was confirmed by VFS in 92% of these patients. Dysphagia in IBM is common but underreported by the vast majority of patients if not specifically asked for. In practice, two questions reliably predict the presence of IP on VFS: ‘Does food get stuck in your throat’ and ‘Do you have to swallow repeatedly in order to get rid of food’. These questions are an appropriate means in selecting IBM patients for further investigation through VFS and eventual treatment.

8 October 2009 in Journal of Neurology
Verified
Journal Article
Open access
PDF file
FCFieke M. Cox
Fieke M. Cox
VDVictoria Delgado
Victoria Delgado
JVJan J. Verschuuren
Jan J. Verschuuren
BBBart E. Ballieux
Bart E. Ballieux
JBJeroen J. Bax
Jeroen J. Bax
UBUmesh A. Badrising
Umesh A. Badrising
The purpose of this study was to explore the prevalence and nature of cardiac abnormalities in sporadic inclusion body myositis (sIBM). Fifty-one sIBM patients were cross-sectionally studied using history-taking, physical examination, measurements of serum creatine kinase activity, the MB fraction (CK-MB), cardiac troponin T (cTnT) and I (cTnI), a 12-lead electrocardiogram (ECG) and 2-dimensional echocardiography. Present cardiac history was abnormal in 12 (24%) out of 51 patients, 12 (24%) patients had abnormalities on ECG, mostly aspecific, and in 12 (24%) patients the echocardiograph showed abnormalities. Elevated CK-MB was present in 42 (82%) patients and 40 (78%) had an elevated cTnT in the absence of acute cardiac pathology. In contrast, in one patient (2%) cTnI was elevated. There was no apparent association between elevated biomarkers, ECG or echocardiographic abnormalities. The prevalence of cardiac abnormalities in sIBM does not seem to be higher than would be expected in these elderly patients. Elevated CK-MB and cTnT levels are common, in contrast to cTnI, but do not reflect cardiac pathology.

17 June 2006
Verified
Journal Article
Closed access
FCF M E Cox
F M E Cox
JCJ H Cornel
J H Cornel
MAM Aramideh
M Aramideh

13 July 2010 in European Journal of Neurology
Verified
Journal Article
Closed access
PDF file
FCF. M. Cox
F. M. Cox
EBE. M. J. Boon
E. M. J. Boon
CLC. A. C. Van Der Lans
C. A. C. Van Der Lans
EBE. Bakker
E. Bakker
JVJ. J. G. M. Verschuuren
J. J. G. M. Verschuuren
UBU. A. Badrising
U. A. Badrising